Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 270 participants.

Also called NCT06704672

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 270 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06704672
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Poland, Türkiye (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06704672. Randomized; no masking; primary purpose diagnostic. Start 2025-04-14 (actual); primary completion 2026-11-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
Condition
Type 1 Diabetes Mellitus
Condition
Type 2 Diabetes Mellitus
Intervention (Device)
Accu-Chek SmartGuide CGM Solution
Intervention (Device)
Accu-Chek SmartGuide Sensor and Blinded Apps
Intervention (Device)
SMBG Device
Lead sponsor
Hoffmann-La Roche (class: industry)
Collaborator
Roche Diabetes Care (class: industry)

Record details

Record id
cardio:ct-nct06704672
Content hash
d8b538c71db36ff5510aab74d9feb6bf9b57eaf3ba6680a6dfea41d56c44ca1f